New combo aims to shrink liver tumors before surgery
Disease control
Recruiting now
This phase 2 trial tests whether giving a combination of targeted therapy (apatinib), immunotherapy (camrelizumab), and a procedure called TACE before surgery can help shrink centrally located liver tumors in people with stage B liver cancer. The goal is to make surgery more effe…
Phase: PHASE2 • Sponsor: Wei Zhang • Aim: Disease control
Last updated Jun 26, 2026 14:09 UTC